Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 573-579

  Guo, Yanping ^a   Jacobs, Stephen C ^a,b   Kyprianou, Natasha ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER;

EID: 0030979568     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.0.CO;2-D     Document Type: Article

References (24)

1. GARRIGUE-ANTAR, L., MUNOZ-ANTONIA, T., ANTONIA, S.J., GESMONDE, J., VELUCCI, V.F. and REISS, M., Missense mutations of the transforming growth factor β type-II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55, 3982-3987 (1995).
2. GEISER, A.C., BURMESTER, J.K., WEBBINK, R., ROBERTS, A.B. and SPORN, M.B., Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines. J. biol. Chem., 267, 2588-2593 (1992).
3. GLEASON, D.F., Histologic grading and clinical staging of prostatic carcinoma, In: Tannenbaum and Feibiger (eds.), Urologic pathology: the prostate, pp. 171-197, Philadelphia (1977).
4. ISAACS, J.T., Antagonistic effect of androgens on prostatic cell death. Prostate, 5, 54-58 (1984).
5. KADIN, M.E., CAVILL-COLL, M.N., GERTZ, R., MASSAGUÉ, J., CHEIFEZ, S. and GEORGE, D., Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. nat. Acad. Sci. (Wash.), 91, 6002-6006 (1994).
6. KIM, I.Y., AHN, H.-J., ZELNER, D.J., SHAW, J.W., LANG, S., KATO, M., OEFELEIN, M.G., MIYAZONO, K., NEMETH, J.A., KOZLOWSKI, J.M. and LEE, C. Loss of expression of transforming growth factor-β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res., 2, 1255-1261 (1996).
7. KYPRIANOU, N. and ISAACS, J.T., Identification of a cellular receptor for TGF-β in the rat ventral prostate and its negative regulation by androgens. Endocrinology, 123, 2124-2131 (1988).
8. KYPRIANOU, N. and ISAACS, J.T., Expression of transforming growth-β in the rat ventral prostate during castration-induced cell death. Mol. Endocrinol., 3, 1515-1522 (1989).
9. LAIHO, M., WEISS, F.M.B. and MASSAGUÉ, J., Concomitant loss of transforming growth factor β-receptors type I and type II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. biol. Chem., 265, 18518-18524 (1990).
10. LIN, H.Y., WANG, X., NG-EATON, E., WEINBERG, R.A. and LODISH, H.F., Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785 (1992).
11. LOPEZ-CASILLAS, F., CHEIFEZ, S., DOODY, J., ANDRES, J.L., LANE, W.S. and MASSAGUÉ, J., Structure and expression of the membrane proteoglycan, a component of the TGF-β receptor. Cell, 67, 785-795 (1991).
12. MARKOWITZ, S., WANG, J., MYEROFF, L., PARSONS, R., SUN, L.-Z., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILLSON, J.K.V., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 68, 1336-1338 (1995).
13. MARTIKAINEN, P., KYPRIANOU, N. and ISAACS, J.T., Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology, 127, 2963-2968 (1990).
14. MASSAGUÉ, J., ATTISANO, L. and WRANA, J.L., The TGF-β family and its composite receptors. Trends Cell Biol., 4, 172-178 (1994).
15. MORION, D.M. and BARRACK, E.R., Modulation of transforming growth factor-β1 effects in prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res., 55, 2596-2602 (1995).
16. PARK, K., KIM, S.-J., BANG, Y.-J., PARK, J.-G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β type II receptor gene in human gastric cells: correlation with sensitivity to TGF-β. Proc. nat. Acad. Sci. (Wash.), 81, 8772-8776 (1994).
17. SUN, L., WU, G., WILLSON, J.K., ZBOROWSKA, E., YANG, J., RAJKARUNANAYEKE, I., WANG, J., GENTRY, L.E., WANG, X.-F. and BRATTAIN, M.G., Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. biol. Chem., 269, 26449-26455 (1994).
18. THOMPSON, T.C., A review: growth factors and oncogenes in prostate cancer. Cancer Cells, 2, 345-354 (1990).
19. TRUONG, L.D., KADMON, D., MCBUNE, B., FLANDERS, K.C., SCARDINO, P.T. and THOMPSON, T.C., Association of TGF-β with prostate cancer: an immunohistochemical study. Hum. Penhol., 24, 4-9 (1993).
20. TU, H., JACOBS, S.C., BORKOWSKI, A. and KYPRIANOU, N., Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-β and Bcl-2 expression. Int. J. Cancer. 69, 357-363 (1996).
21. WIESER, R., ATTISANO, L., WRANA, J.F. and MASSAGUÉ, J., Signaling activity of transforming growth factor type II receptors lacking specific domains in the cytoplasmic region. Mol. cell. Biol., 13, 7239-7247 (1993).
22. WILDING, G., UGMEIR, G., KNABBE, C., FLANDERS, K. and GELLMAN, E., Differential effects of transforming growth β on human prostate cancer cells in vitro. Mol. cell. Endocrinol., 62, 79-87 (1989).
23. WILLIAMS, R.H., STAPLETON, A.M.F., YANG, G., TRUONG, L.D., ROGERS, E., TIMME, T.L., WHEELER, T.M., SCARDINO, P.T. and THOMPSON, T.C., Reduced levels of transforming growth factor β receptor type II in human prostate cancer: an immunohistochemical study. Clin. Cancer Res., 2, 635-640 (1996).
24. WRANA, J., ATTISANO, L., WIESERT, R., VENTURA, F. and MASSAGUÉ, J., Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370, 341-347 (1994).